In March, ADAPT Pharma, a subsidiary of Emergent BioSolutions and CSG Associate, announced the expansion of its program offering free NARCAN Nasal Spray – the leading community use naloxone – to U.S. high schools and eligible colleges and universities. NARCAN Nasal Spray 4mg is the only FDA-approved, needle-free formulation of naloxone for the emergency treatment of a known or suspected opioid overdose. As part of this effort, ADAPT Pharma will:
• Expand free NARCAN Nasal Spray availability by eliminating the prior 20,000 cartons cap for eligible colleges and universities
• Double the allocation to high schools from one free carton (two 4mg doses) to two free cartons (four 4mg doses)
• Extend the term of the free NARCAN Nasal Spray offer until it is in every high school and eligible college and university in the United States